1.Webber AL, Wood J. Amblyopia: Prevalence, natural history, functional effects and treatment.
Clin Exp Optom. 2005;88(6):365-75.##
2. Simons K, Preslan M. Natural history of amblyopia untreated owing to lack of compliance.
Br J Ophthalmol. 1999;83(5):582-7.##
3. Hoyt CS. Taylor D. Pediatric ophthalmology and strabismus: Expert Consult. 4th ed. Toronto, Saunders Elsevir, 2013. P. 276. ##
4. Moseley M, Fielder A. Amblyopia: a multidisciplinary approach. Boston: Butterworth-Heimann Co. 1997.##
5. Berg A., Allen JD., Calonge N., Frame P., Garsia J., harris R. Johnson MS., Klein JD, Loveland-Cherry C, Moyer VA, Orlen CT, Siu AL. U.S. Preventive Services Task Force. Screening for visual impairment in children younger than age 5 years. Annal Family Med 2004; 193(2): 263-266.##
6. Simons K. Amblyopia characterization, treatment, and prophylaxis. Surv Ophthalmol 2005; 50)2(:123-66.##
7. Rajavi J. Thoughts of amblyopia News. Journal of Research in Medicine 1386;31)2(:105-106.[In Persian]##
8. Webber AL, and Wood J. Clin Exp Optom. Amblyopia: prevalence, natural history, functional effects and treatment. 2005; 88)6(: 365-375. ##
9. Snowdonb SK, Stewart-Brown SL. Preschool vision screening. Health Technol Assess. 1997; 1:1-83.##
10. Umphred DA, Jewell MJ. Neurological rehabilitation. 5th edition. USA. Mosby; 2007. P. 981-90.##
13. Training Guide examiners. Available at:
www.behzisti.ir .Accessed Oct 15, 2013.##
14. Nelson LB, Olitsky SE. Harley's Pediatric ophthalmology. 5th edition. USA. Lippincott Williams & Wilkins; 2005. P. 123-125.##
15. Kemper AR, Uren RL, Clark SJ. Barriers to follow-up eye care after preschool vision screening in the primary care setting: Findings from a pilot study. National Institutes of Health 2006; 10 (5): 476-478.##
16. Aggarwal KR. Understanding and misunderstandings about patching for amblyopia therapy–perception of Indian parents. AIOC 2010 Proceedings, Pediatric Ophthalmology Session 2010. P: 537-542.##
17. Lanca C. Risk factors for non-compliance using occlusive therapy: a case study. In World Congress of Paediatric Ophthalmology and Strabismus. Barcelona, 2009. Available from: http://hdl.handle.net/10400.21/354. Access Aug 25, 2015.##
18. Castanon Holguin AM, Congdon N, Patel N, Ratcliffe A, Esteso P, Toledo Flores S, Gilbert D, Pereyra Rito MA, Munoz B. Factors associated with spectacle-wear compliance in school-aged Mexican children. Invest Ophthalmol Vis Sci. 2006; 47(3): 925-8.##
19.
Stewart CE, Fielder AR. Stephens DA, Moseley MJ. Design of the Monitored Occlusion Treatment of Amblyopia Study (MOTAS). Br J Ophthalmol. 2002; 86(8): 915–919.##
20. Dixon-Woods M, Awan M, Gottlob I. Why is compliance with occlusion therapy for amblyopia so hard? A qualitative study. Arch Dis Child. 2006; 91(6): 491–494.##
21. Menon V, Chaudhuri Z, Saxena R, Gill K, Sachdeva MM. Factors influencing visual rehabilitation after occlusion therapy in unilateral amblyopia in children.
Indian J Med Res. 2005 Dec;122(6):497-505.##
22. Loudon SE, Polling JR, Simonsz HJ. Electronically measured compliance with occlusion therapy for amblyopia is related to visual acuity increase.
Graefes Arch Clin Exp Ophthalmol. 2003;241(3):176-80.##